France said on Wednesday the first trials of a drug to treat Ebola in Guinea had been encouraging and appeared to accelerate the recovery process of patients, President Francois Hollande’s office said in a statement.

Trials of an experimental Japanese drug – Avigan, or favipiravir – developed by Toyama Chemical, a subsidiary of Japan’s Fujifilm, began at a treatment center in Guinea in mid-December.

5 Comments

Leave a Comment